The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years, the ...

Doctors have shared their top tips for travelling with eczema, offering some wise words for people who find heading to ...

World Atopic Eczema Day 2025 calls for early intervention, better care and greater awareness of the hidden toll of atopic ...

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...

Nektar Therapeutics (Nasdaq: NKTR) today announced new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, ...

Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...

Adults with atopic dermatitis, whether diagnosed during childhood or adulthood, experienced higher rates of suicidal thoughts ...

Exercising with eczema needs care. Sweat, friction, and heat can trigger flare-ups. Opt for breathable fabrics, short ...

A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals ...

US drug developer Nektar Therapeutics saw its shares rise 9% to $55.66 following release of new data from the ongoing REZOLVE ...